The Toscafund takeover deadline has been extended again by Spire Healthcare

Spire Healthcare has just been granted another reprieve as Toscafund Asset Management keeps working on a bid for the UK healthcare group at 250 pence per share in cash.

Toscafund, the second-largest shareholder of Spire, is planning a bid to acquire all the issued and future share capital of the company. The proposal would also contain an optional unlisted rollover equity option for any existing shareholders who might want to continue to have an interest after the possible transaction.

Toscafund has conducted due diligence on Spire, and is awaiting finalization of financing arrangements, the parties said, which are “close to completion”. The UK Takeover Panel has agreed to a two-month extension to the deadline, in line with Spire’s board request.

Takeover Code and Offer Conditions

At this time, Toscafund will either be making a good faith effort to make an offer under the UK Takeover Code or confirm that it is not going to make an offer. The deadline could be extended again with the consent of the Takeover Panel.

However, although discussions are at an advanced stage, Spire has also emphasized that there is no certainty that Toscafund will be able to make a binding offer in the end. Toscafund has also reserved the right to modify the proposed value or the terms or the structure of any transaction in an event allowed under the Takeover Code.

This is included in the rights to limit the offer price in the face of Spire’s announcement, declaration or payment of a dividend or any other distribution to shareholders before the completion of a potential transaction.

Financial Performance and Stock Valuation

The recent extension does not extend the offer period, but rather provides more time for Toscafund to finalize its financing and transaction documentation. The operational performance and cash generation have been solid, and the cash flow conversion from operating performance to net income is still relatively poor, but Spire’s underlying outlook is good.

Technical indications have also been supportive as the shares have shown a clear uptrend with investors evaluating the possibility of the stock being gobbled up. The valuation aspect is more important, though; Spire trades at a somewhat higher PE ratio and has a lower dividend yield than it has over the last few years.

Company Overview and Operations

Spire Healthcare Group is a major independent healthcare group in the UK, with a presence in 38 hospitals and over 60 clinics throughout England, Wales and Scotland. The group operates over 8,800 consultants with a patient population of both NHS patients and customers paid for by employers and insurers, as well as private patients. It is also a large supplier of NHS talking therapies and orthopaedic procedures.

In 2025, Spire treated over 1.36 million patients and is a member of the FTSE 250.

Toscafund Takeover Deadline Extended Again

The Toscafund takeover process involving Spire Healthcare has been extended for a fifth time, giving Toscafund additional time to finalize its potential acquisition of the UK private healthcare provider. The latest deadline is September 3, 2026, at 5:00 p.m. London time.

Spire Healthcare has been at the center of a closely watched takeover process as discussions over a potential acquisition continue. The proposed transaction could value the private healthcare provider at around £1 billion, making it one of the more significant deals in the UK healthcare sector.

The repeated deadline extensions indicate that negotiations have required additional time. While discussions have progressed, a formal offer is still dependent on several conditions, including financing arrangements, due diligence, and completion of transaction documentation.

Why the Deal Matters

A successful acquisition could significantly change Spire Healthcare’s ownership structure. The company operates hospitals and clinics across the UK and provides a wide range of private healthcare services, including diagnostics, surgery, and specialist treatments.